TY - JOUR T1 - Management of acute ischemic stroke under routine infection prevention practices for COVID-19 JF - Journal of NeuroInterventional Surgery JO - J NeuroIntervent Surg SP - e10 LP - e10 DO - 10.1136/neurintsurg-2020-016803 VL - 13 IS - 6 AU - Bin Yang AU - Tao Wang AU - Jian Chen AU - Yanfei Chen AU - Yabing Wang AU - Peng Gao AU - Guilin Li AU - Fei Chen AU - Long Li AU - Zheng Wang AU - Hongqi Zhang AU - Haiqing Song AU - Qingfeng Ma AU - Liqun Jiao Y1 - 2021/06/01 UR - http://jnis.bmj.com/content/13/6/e10.abstract N2 - We greatly appreciate the comments made by Leslie-Mazwi et al.1 As they mentioned, the lack of a 90-day modified Rankin Scale (mRS) was a major limitation of our study. In order to share our first-hand experience as soon as possible during the pandemic, we only reported 7- day outcomes. However, the 90-day follow-up was pre-planned, as we stated in response to peer review comments. As shown in figure 1, a good clinical outcome (mRS ≤2) was seen in 52.9% (9/17) in the pandemic group compared with 39.4% (13/33) in the pre-pandemic group; this difference was not statistically significant (p=0.361). No significant difference was identified for either 90-day mortality (4/17 (23.5%) vs 5/33 (15.2%), p=0.732) or 90-day National Institutes of Health Stroke Scale score (4, IQR 1–12 vs 8, IQR 4–10; p=0.320) in the pandemic and pre-pandemic groups, respectively. However, the small sample size may partially account for this equivalence, therefore future prospective multicenter studies are warranted.Figure 1 Distribution of functional outcomes at 90 days. … ER -